Acro Biomedical Co., Ltd.
ACBM· OTC
ACBMAcro Biomedical Co., Ltd.
Filed Aug 3, 2016 · 10-Q · 34 days after period end · 0001640334-16-001481
| Metric | Q3 2016 | Q3 2015 |
|---|---|---|
| Net Income | -$17.13K | -$18.00 |
| EPS Diluted | $0.00 | $0.00 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Acro Biomedical Co., Ltd. · CIK 1622996 · Engraved from SEC EDGAR
ended Jun 30, 2016 · filed Aug 3, 2016 · 34 d after period end
